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Background: Liver involvement in severe Plasmodium falciparum infection is commonly a significant cause of
morbidity and mortality among humans. The clinical presentation of jaundice often reflects a certain degree of liver
damage. This study investigated the liver pathology of severe P. falciparum malaria as well as the regulation and
occurrence of apoptosis in cellular components of formalin-fixed, paraffin-embedded liver tissues.
Methods: The liver tissues used in the study came from patients who died from P. falciparum malaria with
hyperbilirubinaemia (total bilirubin (TB) ≥ 51.3 μmol/L or 3 mg/dl) (12 cases), P. falciparum malaria without
hyperbilirubinaemia (TB < 51.3 μmol/L) (10 cases); and patients who died due to accidents, whose liver histology was
normal (the control group) (10 cases). The histopathology of the liver tissue was studied by routine histology method.
Caspase-3 and nuclear factor kappa B (NF-κB) p65 expressions were determined using immunohistochemistry.
Results: The severity of liver histopathology, occurrence of apoptosis and NF-κB p65 activation in P. falciparum malaria
were associated with higher TB level. Significant correlations were found between NF-κB p65 expression and apoptosis
in Kupffer cells and lymphocytes in the portal tracts.
Conclusions: Hyperplastic Kupffer cells and portal tract inflammation are two main features found in the liver tissues of
severe P. falciparum malaria cases. In addition, NF-κB is associated with Kupffer cells and lymphocyte apoptosis in severe
P. falciparum malaria.
Keywords: Malaria, Plasmodium falciparum, Liver, Kupffer cells, Bilirubin, Nuclear factor kappa B, NF-κB p65, Cleaved
caspase-3, Apoptosis, ImmunohistochemistryBackground
Plasmodium falciparum malaria is a life-threatening in-
fectious disease that remains a major global health prob-
lem. The severe manifestations often present clinically as
cerebral malaria, pulmonary oedema, acute kidney in-
jury, hypoglycaemia, lactic acidosis, anaemia and liver
involvement [1]. Plasmodium falciparum malaria causes
clinical jaundice in 2.5-5.3% of cases in endemic areas
[2,3]. The liver is an important organ involved during
the hepatic stage of the malaria parasite’s life cycle,
where malaria sporozoites develop into merozoites. The* Correspondence: parnpen.vir@mahidol.ac.th
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article, unless otherwise stated.merozoites are then released into the circulation and enter
the erythrocytic stage. In the erythrocytic stage, parasitized
red blood cells (PRBCs) become sequestered in small
blood vessels. The degraded haemozoin pigment is then
engulfed by local tissue macrophages, such as Kupffer cells
and alveolar macrophages. Common histopathological
findings of the liver in P. falciparum malaria include react-
ive Kupffer cells, retention of haemozoin pigment and
minimal PRBC sequestration [4,5]. An ultrastructural
study reported an association between high PRBC load in
the livers of malaria patients with jaundice, hepatomegaly
and liver enzyme elevation [6].
Apoptotic changes occur in a variety of cellular sys-
tems and involve both physiologic and pathologic
changes. While apoptotic change in the liver have not
been documented in human malaria, changes have beenntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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hepatocytes [7,8] and during the hepatic stage in Kupffer
cells [9]. This process of programmed cell death can be
mediated by various stimuli, including hormones, cyto-
kines, growth factors, bacterial or viral infections and the
immune response [10]. Cell apoptosis is regulated via two
major pathways: the intrinsic or mitochondrial pathway
and the extrinsic or death-receptor pathway. Initiator cas-
pases, such as caspase-8 or −9, play a regulatory role by
activating downstream effector caspases, such as caspase-
3, −6, or −7 [11]. NF-κB has been shown to regulate the
apoptotic program in various cell types, either as an up-
regulating response or as an apoptosis blocker [12]. Evi-
dence of NF-κB regulating apoptosis was found in the
brain endothelial cells and intravascular lymphocytes in
cerebral malaria [13]. However, no linkage between NF-κB
and apoptosis has been reported in the livers of P. falcip-
arum malaria patients. This study evaluated the liver path-
ology of severe P. falciparum malaria in association with
total bilirubin (TB) level. The occurrence of apoptosis and
its relation to a signaling molecule (NF-κB) in liver tissues
was investigated.Methods
Liver tissue specimens from malaria patients and controls
Specimens were classified into two groups according to the
level of total bilirubin (TB): TB ≥ 51.3 μmol/L (3 mg/dl)
(12 cases) and TB < 51.3 μmol/L (10 cases), based on la-
boratory data. Liver specimens with normal histology
obtained from fatal accident cases (10 cases), served as
the control group. The specimens were obtained from
autopsied cases at the Department of Tropical Pathology,
Faculty of Tropical Medicine, Mahidol University,
Bangkok, Thailand. Control cases came from the same
region. Patients with hepatitis B co-infection, and pa-
tients with glucose-6-phosphate dehydrogenase (G6PD)
deficiency, were excluded from the study. The use of
left-over liver specimens and the study protocol were
reviewed and approved by the Ethics Committee of
the Faculty of Tropical Medicine, Mahidol University
(MUTM 2011-025-01 and MUTM 2011-025-02).Table 1 Histopathological changes and grading schemes used
Histopathologic
changes 0 1
Fatty change No fatty change < 10%
Kupffer cells/HPF < 20/HPF 20-35/HP
Portal tract inflammation < 5% of portal tract area 5-15% of portal
Bile duct proliferation No proliferation Mild prolifer
Sinusoid congestion No congestion Mild conge
Haemozoin deposition No deposition Mild depos
HPF = high power field (magnification 400x).Liver tissue preparation
Left-over liver tissues in paraffin-embedded blocks were
re-embedded with new paraffin medium using standard
histological techniques. Liver tissues were sectioned at
4 μm thickness and placed onto glass slides for histo-
pathological examination and onto positively charged
slides for immunohistochemistry study against cleaved
caspase-3 and NF-κB p65.Histology of liver in severe P. falciparum malaria
Overall liver histopathology was classified based on the
severity of six histological criteria, namely fatty change,
hyperplastic Kupffer cells, portal tract inflammation, bile
duct proliferation, sinusoidal congestion and haemozoin
deposition. Quantification was performed under high
(400x) magnification. The severity level of each histo-
pathological change was graded on a scale from 0 to 3,
according to semi-quantitative assessment (Table 1). The
highest possible total score was 18 (6 histological criteria x 3
as highest scale). Score 0 meant no histopathological
change and score 18 referred to most severe histo-
pathological change. Microscopic evaluation was done
by two observers (PV and CP). A third person was
asked to score the histopathological changes if more
than 2 grading variations were observed.Immunohistochemical staining of cleaved caspase-3 and
NF-κB p65
The 4 μm paraffin sections were deparaffinized and rehy-
drated by sequential immersion in a graded series of alco-
hol, then transferred into water for 5 mins. To inhibit
endogenous peroxidase activity, the sections were incu-
bated with 3% H2O2 for 5 mins. The sections were then
heated in a microwave oven (in 0.1 M sodium citrate buf-
fer, pH 6.0 for cleaved caspase-3 and 0.1 M Tris–HCl buf-
fer, pH 9.0 for NF-κB p65) for 20 mins for epitope
retrieval. After washing with phosphate buffered saline
(PBS), pH 7.4, sections were incubated for 30 mins with
normal serum as blocking solution to reduce the non-
specific background, then cooled to room temperature




F 36-50/HPF > 50/HPF
tract area 16-30% of portal tract area > 30% of portal tract area
ation Moderate proliferation Severe proliferation
stion Moderate congestion Severe congestion
ition Moderate deposition Severe deposition
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(VECTASTAINW ABC-AP kit (Rabbit IgG) # AK-5001)
for cleaved caspase 3 and avidin-biotin peroxidase com-
plex (VECTASTAINW ABC kit (Mouse IgG) # PK-4002)
for NF-κB p65 (Vector Laboratories, Inc., USA) according
to the manufacturer’s protocol. The sections were incu-
bated with primary antibody; rabbit polyclonal anti-
cleaved caspase-3 (Asp175) antibody (1:200 dilution) (Cell
Signaling Technology, USA) and mouse monoclonal anti-
NF-κB p65 (1:50 dilution) (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA) and incubated overnight at 4˚C in a hu-
midity chamber. The following day, sections were washed
three times with PBS, and incubated with anti-mouse/
rabbit biotinylated secondary antibody (Vector Laborator-
ies, Inc., USA) for 30 mins at room temperature and
reacted with avidin-biotin complex (ABC) conjugated
with alkaline phosphatase (AP)/horseradish peroxidase
(HRP) (Vector Laboratories, Inc., USA) for 30 mins. After
washing, enzyme activity was visualized by VectorW Red
substrate kit (Vector Laboratories, Inc., USA) for cleaved
caspase-3, resulting in the formation of a red colour at the
antigen sites and by 3,3′- diaminobenzidine (DAB)
(Vector Laboratories, Inc., USA) for NF-κB p65, pre-
senting as a brown colour. Subsequently, sections were
counterstained with haematoxylin for 1 min, and
mounted with a coverslip.
Cleaved caspase-3 and NF-κB p65 analysis
The presence of immunopositive cells for cleaved
caspase-3 and NF-κB p65 was recorded as percentages.
In addition, immunostaining intensity was scored from
0–3 (0-negative staining, 1- mild, 2- moderate, and 3-
strong immunostaining). Total score was calculated by
multiplying percentage immunopositive cells and inten-
sity, a method used by Punsawad et al. 2013 [13].
Measurement of Kupffer cell length
Ten representative views of H&E-stained liver sections
were randomly photographed at 400x magnification usingTable 2 Clinical and laboratory parameters of P. falciparum m
Non-hyperbilirubinaemia (TB < 51
Age (years) (p = 0.974)
Sex (M:F)
Days of fever (p = 0.095)
Parasitaemia (/μl) (p = 0.619) 303
Albumin (g/L) (p = 0.006)
AST (U/L) (p = 0.006)
ALT (U/L) (p = 0.049)
Alkaline phosphatase (U/L) (p = 0.049)
Total bilirubin (μmol/L) (p = 0.001)
Direct bilirubin (μmol/L) (p = 0.001)an Olympus Bx41 light microscope (Olympus, Tokyo,
Japan) connected to an Olympus DP20 digital camera
(Olympus, Tokyo, Japan). Kupffer cell length was mea-
sured with the UTHSCSA Image Tool program (devel-
oped at the University of Texas Health Science Center at
San Antonio, TX; freely available from the Internet).Statistical analysis
Data were expressed as mean ± standard error of the
mean (SEM). The normality of distribution was deter-
mined by the Kolmogorov-Smirnov test. Differences be-
tween groups were analyzed by Mann Whitney U-test.
In addition, the correlations of each variable within
groups and pertinent clinical data were calculated using
Spearman’s rank correlation (rs). Statistical analysis was
performed using SPSS version 17.0 software (SPSS, IL,
USA). A p value < 0.05 was considered significantly
different.Results
Malaria patients
Twenty-two liver specimens were collected from P. fal-
ciparum malaria cases, consisting of 12 cases with
hyperbilirubinaemia (total bilirubin (TB) ≥ 51.3 μmol/L
or 3 mg/dl) and 10 cases without hyperbilirubinaemia
(TB < 51.3 μmol/L). Ten cases with normal liver histo-
pathology served as controls. Table 2 summarizes the
mean age, sex, days of fever pre-admission, parasitaemia
and important liver function tests of the malaria pa-
tients. Significant differences between two groups were
noted in the levels of albumin, aspartate aminotransfer-
ase (AST), alanine aminotransferase (ALT), alkaline
phosphatase, total and direct bilirubin (p value < 0.05).
Common associated complications were cerebral malaria
(70.00% for non-hyperbilirubinaemia and 33.33% for
hyperbilirubinaemia groups) and acute kidney injury
(33.33% for hyperbilirubinaemia group).alaria patients
.3 μmol/L) (n = 10) Hyperbilirubinaemia (TB ≥ 51.3 μmol/L) (n = 12)
25.8 ± 3.95 26.17 ± 4.28
6:4 10:2
4.1 ± 0.82 5.83 ± 0.77
,186.67 ± 151,070.30 391,501.40 ± 183,362.30
33.2 ± 0.17 25.3 ± 0.13
72.00 ± 21.41 266.33 ± 64.93
49.17 ± 8.23 126.79 ± 29.22
8.42 ± 2.62 20.07 ± 4.33
30.61 ± 0.31 441.60 ± 5.39
8.55 ± 0.15 217.17 ± 2.73
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Figure 1 displays histopathological changes of the liver
in severe P. falciparum malaria. Morphologically, hepa-
tocytes and endothelial cells (ECs) in the liver were ge-
nerally unaffected in severe P. falciparum malaria. Fatty
change and bile duct proliferation were not features of
P. falciparum infection. Hyperplastic Kupffer cells, por-
tal tract inflammation, sinusoidal congestion and haemo-
zoin pigment deposition were important pathological
hallmarks related to higher TB levels (Table 3). The total
histopathological grading score showed the overall
changes and was found to be highest among the group
of malaria patients with hyperbilirubinaemia (12/18).
Figure 1 (A-C) illustrates a normal portal tract, consis-
ting of hepatic vein, hepatic artery, and bile duct, with
surrounding hepatocytes. Very few inflammatory cells
are noted within the portal tract. Minimal fatty change is
sometimes observed (Figure 1C). Liver tissues from mal-
aria patient without hyperbilirubinaemia show enlarged
sinusoidal area, haemozoin pigment within the hyper-
plastic Kupffer cells, and inflammatory cells within the
portal tract (Figure 1, D-F). In hyperbilirubinaemia
group (Figure 1, G-I), liver tissues show dense inflamma-
tory cells infiltration in the portal tract. At higher mag-























Figure 1 Histopathological changes of liver tissue from normal contro
hyperbilirubinaemia (D-F) and from severe P. falciparum malaria patie
200x magnification; bars are 50 μm. Other images are at 400x magnificatio
B- bile duct, S- sinusoidal area, CV- central vein, arrowheads- Kupffer cells, scontain haemozoin pigment. Sinusoidal areas are often
congested. Central vein contains numerous PRBCs.
Fatty change, hyperplastic Kupffer cells and portal
tract inflammation were quantified in each group
(Table 4). There was no significant difference between
fatty changes in the livers of the P. falciparum malaria
groups and the normal controls (all p > 0.05). However,
hyperplastic Kupffer cells and portal tract inflammation
were significantly higher in the malaria groups compared
with the normal controls and highest in the livers of the
P. falciparum patients with hyperbilirubinaemia. The
number of hyperplastic Kupffer cells were increased in
the malaria group with hyperbilirubinaemia (52.21 ±
2.32/high power field (HPF)), compared with the normal
liver group (9.65 ± 0.67/HPF) (p < 0.001) and the malaria
group without hyperbilirubinaemia (32.05 ± 3.34/HPF)
(p < 0.001). Generally, Kupffer cell contains packed hae-
mozoin pigment within the cytoplasm. Positive correla-
tions were evident between TB and the number of
Kupffer cells (rs = 0.551, p = 0.018) and between TB
and % lymphocytes in the portal tract (rs = 0.743. p =
0.020). In terms of Kupffer-cell length (Figure 2), the size
of Kupffer cells as measured and analysed by Image Tool
software showed significant numbers of reactive Kupffer


















ls (A-C), from severe P. falciparum malaria patients without
nts with hyperbilirubinaemia (G-I). Images A and G are shown at
n; bars are 20 μm. H– hepatocytes, A- hepatic artery, V- hepatic vein,
tar- fatty change, asterisks- inflammatory cells, arrows- PRBCs.




Normal liver Non-hyperbilirubinaemia (TB < 51.3 μmol/L) Hyperbilirubinaemia (TB ≥ 51.3 μmol/L)
Fatty change 0 0 0
Kupffer cells hyperplasia 0 1 3
Portal tract inflammation 1 2 3
Bile duct proliferation 0 0 0
Sinusoid congestion 0 2 3
Haemozoin deposition 0 3 3
Total histological score 1/18 8/18 12/18
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(p < 0.001) and the non-hyperbilirubinaemia group
(p < 0.001).Occurrence of apoptosis in the livers of severe P.
falciparum malaria cases
Apoptosis was evaluated using monoclonal antibody
against cleaved caspase-3, the final apoptotic pathway.
The occurrence of apoptosis in the hepatocytes was neg-
ligible even in the severe P. falciparum malaria with
hyperbilirubinaemia group. Figure 3 A-C illustrates the
occurrence of apoptosis in the liver tissues of severe P.
falciparum malaria cases, compared with the normal
controls. Percentage apoptosis for Kupffer cells and lym-
phocytes within the portal tracts is shown in Figure 4.
The data show that both Kupffer cell and lymphocyte
apoptosis were significantly increased in group with
severe P. falciparum malaria with hyperbilirubinaemia
compared with the non-hyperbilirubinaemia groups (p =
0.030 and p = 0.009, respectively) and the normal con-
trols (all p < 0.001) (Figure 4A and B). The Kupffer cells
and lymphocytes in the non-hyperbilirubinaemia group
also expressed significantly higher levels of apoptosis
than the normal controls (p = 0.005 and p = 0.073, re-
spectively). Since immunostaining intensity is an import-
ant factor in evaluating the degree of protein expression,
a total score incorporating percentage apoptosis and im-
munostaining intensity was also used to compare apop-
tosis in the liver. The total scores for Kupffer cell andTable 4 Quantification of fatty changes, hyperplastic Kupffer
falciparum malaria patients compared with the control group
Histopathological changes Normal liver
(n = 10)
Fatty changes (%/HPF) 0.59 ± 0.25
Hyperplastic Kupffer cells (count/HPF) 9.65 ± 0.67
Portal tract inflammation (%) 5.49 ± 1.20
a Significant difference compared with normal controls, b Significant difference betw
Whitney U-test.lymphocyte apoptosis are shown in Figure 4. A similar
trend to the percentage data was observed.
NF-κB p65 expression in the livers of severe P. falciparum
malaria
NF-κB p65 expression and apoptosis in the livers of severe
P. falciparum malaria were investigated. NF-κB p65 ex-
pression in Kupffer cells and portal lymphocytes is shown
in Figure 5. In both Kupffer cells and lymphocytes, NF-κB
p65 expression was significantly increased in the group
with severe P. falciparum malaria with hyperbilirubinae-
mia, compared with non-hyperbilirubinaemia group
(p = 0.030 and p = 0.009, respectively) and normal
controls (all p < 0.001). The malaria group without
hyperbilirubinaemia showed significantly higher levels
of NF-κB p65 expression in the Kupffer cells and
lymphocytes than the normal controls (p = 0.005 and
p = 0.007, respectively).
Correlation between apoptosis and NF-κB p65 expression
A significant positive correlation was found between
cleaved caspase-3 and NF-κB p65 immunopositive cells
in Kupffer cells (rs = 0.713, p < 0.001), and lymphocytes
in the portal tracts (rs = 0.741, p < 0.001) (Figure 6). Both
the expression of cleaved caspase-3 and NF-κB p65 were
positively correlated with TB (Kupffer cells: rs = 0.707,
p = 0.001 and rs = 0.853, p < 0.001, respectively) (lympho-
cytes: rs = 0.490, p = 0.039 and rs = 0.636, p = 0.008, re-
spectively). Hyperplastic Kupffer cells were positively
correlated with cleaved caspase-3 (rs = 0.617, p = 0.001)cells and portal inflammation in the livers of P.
Non-hyperbilirubinaemia
(TB < 51.3 μmol/L) (n = 10)
Hyperbilirubinaemia
(TB ≥ 51.3 μmol/L) (n = 12)
1.71 ± 0.46 1.97 ± 0.67
32.05 ± 3.34a 52.21 ± 2.32a,b
17.1 ± 1.62a 32.79 ± 2.48a,b



























Figure 2 Length of Kupffer cells as measured and analyzed by
Image Tool software. Significant differences in Kupffer cell length
were observed between the severe malaria groups (with and
without hyperbilirubinaemia) and the normal controls (a) and
between the hyperbilirubinaemia and non-hyperbilirubinaemia
groups (b) (p < 0.05). Data are presented as a mean ± SEM.
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degree of portal tract inflammation was also positively
correlated with cleaved caspase-3 (rs = 0.612, p = 0.001)
and NF-κB p65 (rs = 0.519, p = 0.002) expression. On the
other hand, no significant association was seen between
both NF-κB p65 and cleaved caspase-3 expression of
Kupffer cells and portal lymphocytes, and clinical data
(age, sex, days of fever pre-admission, parasitaemia and
important liver function tests.
Discussion
Liver pathology in severe P. falciparum malaria
The present study shows a rise in liver transaminases









Figure 3 Representative immunohistochemical staining patterns of cl
showing negative staining for hepatocytes and Kupffer cells (A,D); in
hyperbilirubinaemia (B,D) and with hyperbilirubinaemia (C,F). Hepatoc
the hepatic cord, within the sinusoidal area. In the normal liver, Kupffer cells a
(A) and show few NF-κB p65 (D) compared with severe P. falciparum malaria
where Kupffer cells are enlarged and hyperplastic. Most Kupffer cells containin
markers. Numerous Kupffer cells show apoptosis (C) and NF-κB p65 expressio
are at 400x magnification; bars are 20 μm.hyperbilirubinaemia (TB ≥ 51.3 μmol/L). Clinical jaun-
dice in P. falciparum can be caused by several factors,
i.e. intravascular haemolysis from parasitized red blood
cells (PRBCs), G6PD deficiency-related haemolysis or anti-
malarial drugs, disseminated intravascular coagulation
(DIC) or co-existing septicaemia-induced hepatitis [14,15].
The histopathology of the liver in severe malaria has been
previously studied. However, the present study demon-
strated certain morphological variations in the liver from
other reports, such as an abundant chronic inflammatory
cell response and an absence of liver cell necrosis. Liver
changes in severe malaria often include hyperplastic
Kupffer cells [4,5,16-18], fatty change [16,17], portal
tract inflammation [17], cholestasis [16,17], liver cell ne-
crosis [4,16,18], sequestration of PRBCs and the depo-
sition of haemozoin pigment [4,5,16,18]. The present
study documented hyperplastic Kupffer cells with scat-
tered haemozoin deposition and portal inflammation as
the most common histological changes in the livers of
severe P. falciparum malaria cases. The enlarged Kupffer
cells were confirmed quantitatively using Image Tool
software. The immune response in the liver to PRBCs
primarily involves the activation of Kupffer cells. The re-
cruitment and activation of Kupffer cells and macro-
phages in the spleen and bone marrow are important
for the clearance of malaria parasites [19]. Portal tract
inflammation consists mainly of lymphocytes and a few
plasma cells (Table 4), in contrast with mild inflam-
mation (portal and lobular lymphocytic infiltrates) reported
earlier [5]. An acute inflammatory process involving




eaved caspase-3 (A-C) and NF-κB p65 (D-F) in a normal liver
the livers of a severe P. falciparum malaria case without
ytes are generally unaffected. Arrows show Kupffer cells lying next to
re small, non-reactive and rarely express the cleaved caspase-3 marker
without hyperbilirubinaemia (B,E) and with hyperbilirubinaemia (C,F)
g haemozoin pigment (arrowheads) expressed apoptotic and NF-κB p65




































































Figure 4 Cleaved caspase-3 expression in Kupffer cells and lymphocytes in the portal tracts. Significant differences were observed
between the severe malaria groups (with and without hyperbilirubinaemia) and the normal controls (a), and between the hyperbilirubinaemia
and non-hyperbilirubinaemia groups (b) (p < 0.05), in both percentage and total scores for cleaved caspase-3 expression in Kupffer cells (A) and
lymphocytes in the portal tracts (B). Data are presented as mean ± SEM.
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necrosis in P. falciparum was not a striking finding in this
study. It has also been reported as a rare event in some
other studies [5,18]. However, the incidence of hepatic ne-
crosis may be as high as 41% [4] and severe cases of cen-
trizonal necrosis have been documented [18]. This change
has been reported to be secondary to suppression of bili-
rubin excretion by PRBCs or metabolic acidosis rather
than hepatitis per se [14]. Sequestration of PRBCs is a
common finding and depends on malaria parasite load.
Apoptosis and NF-κB p65 in the liver of severe P. falciparum
malaria cases
Among various cells evaluated in the liver tissue, Kupffer





























Figure 5 NF-κB p65 expression in Kupffer cells and lymphocytes in th
for NF-κB p65 expression were observed in Kupffer cells (A) and lymphocy
and without hyperbilirubinaemia) and the normal controls (a) and between
(b) (p < 0.05). Data are presented as mean ± SEM.changes in severe P. falciparum malaria. Hepatocytes,
bile ducts and ECs failed to show significant apoptotic
changes. P. falciparum has been shown to induce apop-
tosis in human cells, such as in lymphocytes [13,20-22],
neurons [13], glial cells [13], brain ECs [13] and lung
ECs [23]. This may be responsible for clinical manifesta-
tions and progression to severe disease. In animal
models, malaria-induced apoptosis was evident in astro-
cytes [24], lymphocytes [25], liver and spleen [8,25]. Dur-
ing the liver stage, however, hepatocytes are usually
spared from the apoptotic process, allowing merozoites
to be released into the circulation, suggesting that mal-
aria sporozoites can block pro-apoptotic pathways [26].
The present study focuses on liver changes in the



























e portal tracts. Significant differences in percentage and total score
tes in the portal tracts (B) between the severe malaria groups (with
the hyperbilirubinaemia and non-hyperbilirubinaemia groups





 = 0.713; p < 0.001

































n  = 0.741; p < 0.001
A. Kupffer cells 
B. Lymphocytes 
Figure 6 Correlation between NF-κB p65 and cleaved caspase-3
activation. A- in Kupffer cells (Spearman’s ρ test: rs = 0.713, p < 0.001);
B- in lymphocytes within the portal tracts (Spearman’s ρ test:
rs = 0.741, p < 0.001).
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morphologically unaffected and protected from apop-
tosis. Hepatocytes are defended by a barrier of Kupffer
cells, endothelial cells, stellate cells, space of Disse (peri-
sinusoidal space) and Kupffer cells. Moreover, PRBCs
localized within the sinusoidal area are in close contact
with Kupffer cells, the first-line immune defense in the
liver. Recognized as foreign bodies, PRBCs and hae-
mozoin are primarily engulfed by the Kupffer cells. In
contrast, apoptosis in the hepatocytes has been re-
ported in animal models, linked to activation of the
mitochondrial pathway, release of reactive oxygen
species [7,8] and induction by glycosylphophatidyli-
nositol (GPI), a major membrane-associated protein
of P. falciparum [27].
Apoptosis in the Kupffer cells was evidenced by strong
caspase-3 expression. The loaded haemozoin within the
cytoplasm of Kupffer cells can be toxic to these immune
cells. In humans, during the erythrocytic stage, malariaparasites degrade haemoglobin to produce haem and hae-
mozoin which are harmful. Haemozoin can be deposited
in the liver and primarily phagocytized by Kupffer cells,
where it can induce oxidative stress [7], a possible mech-
anism for the induction of apoptosis in Kupffer cells. Du-
ring the liver stage, Kupffer cell apoptosis has also been
detected in a murine model after incubation with Plasmo-
dium yoelii sporozoites [9]. Apoptosis in malaria is repor-
tedly mediated by the Fas-ligand in lymphocytes [20] and
in murine astrocytes [24].
NF-κB has been shown to regulate various cellular
processes such as inflammation, immunity, cell proli-
feration and apoptosis [28]. A previous study documented
NF-κB activation and pro-inflammatory response in
human brain ECs exposed to PRBCs [29]. A recent
study of human brain tissues has demonstrated that
NF-κB is one of the signaling molecules that modu-
lates apoptosis in brain ECs and intravascular leuko-
cytes in fatal cerebral malaria [13]. The present study
documented NF-κB mediating apoptosis in Kupffer
cells and lymphocytes within the portal tract in se-
vere P. falciparum infection.Conclusions
Histopathological changes in the livers of severe P.
falciparum malaria cases are associated with total bili-
rubin levels. Apoptosis of Kupffer cells and portal
tract lymphocytes is a significant finding and is related
to NF-κB activation.
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